SLC44A2 Antikörper (AA 1-706) (HRP)

Produktnummer ABIN8040323

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch SLC44A2 in ELISA, IHC und WB. Es zeigt Reaktivität gegenüber Proben von Maus und Ratte.

Kurzübersicht für SLC44A2 Antikörper (AA 1-706) (HRP) (ABIN8040323)

Target: SLC44A2 (Solute Carrier Family 44, Member 2 (SLC44A2))

Reaktivität: Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SLC44A2 Antikörper ist konjugiert mit HRP

Applikation: ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Produktdetails anti-SLC44A2 Antikörper (HRP)

Bindungsspezifität: AA 1-706

Verwendungszweck: Anti-SLC44A2 Antibody HRP Conjugated

Kreuzreaktivität (Details): No cross-reactivity with other proteins.

Aufreinigung: Immunogen affinity purified.

Immunogen: E.coli-derived mouse SLC44A2 recombinant protein (Position: M1-S706).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.

Lagerung: -20 °C

Informationen zur Lagerung: At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.

Haltbarkeit: 12 months

Details zu SLC44A2

Target: SLC44A2 (Solute Carrier Family 44, Member 2 (SLC44A2))

Andere Bezeichnung: Slc44a2

Hintergrund:

Background: Choline transporter-like protein 2 is a protein that in humans is encoded by the SLC44A2 gene. CTL2 is a multi-pass membrane protein expressed in cells of the inner ear. CTL2 is a possible candidate for autoimmune hearing loss in humans. Present in supporting cells of the inner ear (at protein level). Only isoform 3 is expressed in inner ear vestibular tissue.

Gene Full Name: solute carrier family 44, member 2

Gen-ID: 68682

UniProt: Q8BY89

Pathways: SARS-CoV-2 Protein Interaktom